NRIM 29.03 Northrim Bancorp Inc $NRIM Hit a 52 week high of

New Post Public Reply Private Reply Replies (0) Message Board

Nov 9, 2014 at 3:59 AM

NRIM 29.03 Northrim Bancorp Inc $NRIM Hit a 52 week high of 29.13 Currently at 29.03 +0.43 +1.50% With a day low of 28.48 and a total volume of 11,700.

NRIM Northrim Bancorp Inc Recent Headline News

Northrim BanCorp Up 11.3% Since SmarTrend Uptrend Call (NRIM)
Comtex SmarTrend(R) - Thu Nov 06, 10:06AM CST
SmarTrend identified an Uptrend for Northrim BanCorp (NASDAQ:NRIM) on September 12th, 2014 at $25.66. In approximately 2 months, Northrim BanCorp has returned 11.34% as of today's recent price of $28.57.
NRIM: 29.03 (+0.43)

Northrim BanCorp Shares Up 10.0% Since SmarTrend's Buy Recommendation (NRIM)
Comtex SmarTrend(R) - Thu Oct 30, 9:35AM CDT
SmarTrend identified an Uptrend for Northrim BanCorp (NASDAQ:NRIM) on September 12th, 2014 at $25.66. In approximately 2 months, Northrim BanCorp has returned 9.98% as of today's recent price of $28.22.
NRIM: 29.03 (+0.43)

Northrim BanCorp Has Returned 10.8% Since SmarTrend Recommendation (NRIM)
Comtex SmarTrend(R) - Wed Oct 22, 10:13AM CDT
SmarTrend identified an Uptrend for Northrim BanCorp (NASDAQ:NRIM) on September 12th, 2014 at $25.66. In approximately 1 month, Northrim BanCorp has returned 10.83% as of today's recent price of $28.44.
NRIM: 29.03 (+0.43)

Northrim BanCorp Earns $3.7 Million, or $0.53 Per Diluted Share, in Q314
GlobeNewswire - Tue Oct 21, 3:00PM CDT
Northrim BanCorp, Inc. (Nasdaq:NRIM) ("Northrim"

today reported net profits of $3.7 million, or $0.53 per diluted share, for the third quarter of 2014, compared to $4.4 million, or $0.63 per diluted share, in the second quarter of 2014 and $3.5 million, or $0.53 per diluted share, in the third quarter a year ago. Contributions from the acquisition of Alaska Pacific Bancshares, Inc. ("Alaska Pacific"

increased revenues and helped provide a stable net interest margin, while costs associated with the acquisition of Alaska Pacific and the pending acquisition of Residential Mortgage Holding Company, LLC, the parent company of Residential Mortgage, LLC ("Residential Mortgage"

increased third quarter 2014 operating costs. Year-to-date 2014, net profits increased 11% to $10.7 million, or $1.57 per diluted share, compared to $9.6 million, or $1.46 per diluted share, in the first nine months of 2013.
NRIM: 29.03 (+0.43)

Northern Trust Offers Improved IAS19 Solution to Clients - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 01, 10:15AM CDT
Northern Trust (NTRS) revealed an enhanced reporting solution for the pension fund clients to fulfil the International Accounting Standard 19 (IAS19) requirements as stated under the International Financial Reporting Standards (IFRS).
LION: 15.22 (-0.07), NTRS: 66.90 (+0.07), NRIM: 29.03 (+0.43), NBCB: 37.08 (-0.17)

Preferred Bank Up to Strong Buy on Legacy Issues Resolution - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 30, 4:40PM CDT
On Sep 30, Zacks Investment Research upgraded Preferred Bank (PFBC) to a Zacks Rank #1 (Strong Buy).
PFBC: 26.24 (-0.16), SIVB: 113.00 (+0.08), BSRR: 17.21 (-0.22), NRIM: 29.03 (+0.43)

Will BankUnited's Rising Expenses Dampen Upcoming Results? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 30, 10:20AM CDT
On Sep 24, 2014, we issued an updated research report on BankUnited (BKU).
MRCC: 13.89 (+0.02), AB: 26.25 (+0.50), NRIM: 29.03 (+0.43), BKU: 30.28 (+0.12)

Will Affiliated Managers' Portfolio Expansion Show Results? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Sep 26, 10:20AM CDT
On Sep 19, 2014, we issued an updated research report on Affiliated Managers (AMG).
MRCC: 13.89 (+0.02), AB: 26.25 (+0.50), AMG: 196.70 (+1.50), NRIM: 29.03 (+0.43)

BofI Holding Up to Strong Buy on Robust Fiscal Q4 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Sep 25, 5:25PM CDT
On Sep 25, Zacks Investment Research upgraded BofI Holding, Inc. (BOFI) to a Zacks Rank #1 (Strong Buy).
BOFI: 77.99 (+0.20), CATY: 26.29 (+0.04), BSRR: 17.21 (-0.22), NRIM: 29.03 (+0.43)

JPMorgan's Streamlining Continues: Sells HSAs to Webster - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 24, 6:00PM CDT
JPMorgan (JPM) signed a definitive contract with Webster (WBS) to sell the health savings account (HSA) business managed by its subsidiary, JPMorgan Chase Bank, N.A.
JPM: 61.47 (+0.24), BANC: 11.62 (+0.10), NRIM: 29.03 (+0.43), WBS: 31.86 (+0.34)

Will Westamerica's Top Line Revive or Remain a Concern? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 23, 5:45PM CDT
On Sep 17, 2014, we issued an updated research report on Westamerica (WABC). Prudent expense management continued to be encouraging, whereas stressed top-line growth remained a concern.
WABC: 49.96 (+0.08), BANC: 11.62 (+0.10), BSRR: 17.21 (-0.22), NRIM: 29.03 (+0.43)

Zions' Organic Growth on Track, Should You Stay Invested? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 09, 4:35PM CDT
On Sep 4, 2014, we issued an updated research report on Zions (ZION).
BSRR: 17.21 (-0.22), CVCY: 10.83 (-0.16), NRIM: 29.03 (+0.43), ZION: 29.67 (-0.02)

PrivateBancorp to Redeem $75M Trust Preferred Securities - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 09, 3:55PM CDT
PrivateBancorp, Inc. (PVTB) announced it decision to redeem $75.0 million of its $143.8 million issued and outstanding 10.00% trust preferred securities (TruPS).
STBA: 27.61 (+0.12), PVTB: 32.89 (-0.19), FSGI: 1.97 (+0.01), NRIM: 29.03 (+0.43)

BNY Mellon Faces Top-Line Pressure; Will You Hold the Stock? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 08, 10:10AM CDT
On Sep 1, 2014, we issued an updated research report on BNY Mellon. Robust growth in assets under management (AUM) remained the key strength of BNY Mellon, but the pressurized top line continued to be a chief concern.
FFKT: 22.81 (-0.22), BSRR: 17.21 (-0.22), NRIM: 29.03 (+0.43), BK: 38.91 (+0.14)

First Republic (FRC) Stock Missed the Rally: Time to Dump It? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Sep 05, 4:15PM CDT
On Sep 2, 2014, we issued an updated research report on First Republic Bank (FRC).
BSRR: 17.21 (-0.22), FRC: 51.55 (-0.23), CVCY: 10.83 (-0.16), NRIM: 29.03 (+0.43)

BB&T Expands Globally Despite Revenue & Expense Pressure - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 27, 10:20AM CDT
We issued an updated research report on BB&T Corporation (BBT) on Aug 25, 2014. The company recently reported dismal second-quarter 2014 results.
BBT: 38.18 (-0.08), BSRR: 17.21 (-0.22), CVCY: 10.83 (-0.16), NRIM: 29.03 (+0.43)

Bank of Marin Hits New 52-Week High on Solid Q2 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 22, 2:50PM CDT
Shares of Bank of Marin achieved a new 52-week high of $48.00 in the second half of the trading session on Aug 21. The stock closed the session at $47.66, reflecting a year-to-date return of 10.6%. The trading volume for the session was 41,882 shares.
BSRR: 17.21 (-0.22), CVCY: 10.83 (-0.16), NRIM: 29.03 (+0.43), BMRC: 49.60 (+0.20)

Northrim Bancorp Up to Strong Buy on Recent Acquisition News - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 14, 4:40PM CDT
On Aug 12, Zacks Investment Research upgraded Northrim Bancorp Inc. (NRIM) to a Zacks Rank #1 (Strong Buy).
BSRR: 17.21 (-0.22), CVCY: 10.83 (-0.16), GSBC: 38.74 (-0.41), NRIM: 29.03 (+0.43)

Northrim BanCorp to Acquire Residential Mortgage, LLC for $29.8 Million
GlobeNewswire - Thu Aug 07, 8:31AM CDT
Northrim BanCorp, Inc. ("Northrim"

(Nasdaq:NRIM) and Residential Mortgage Holding Company, LLC, ("RML"

today jointly announced the signing of a definitive purchase agreement (the "Purchase Agreement"

for a wholly-owned subsidiary of Northrim Bank, Northrim Capital Investment Company ("NCIC"

, to acquire 76.5% of the membership interests in RML, the parent company of Residential Mortgage, LLC ("Residential Mortgage"

in a cash transaction currently valued at $29.8 million.
NRIM: 29.03 (+0.43)

Is Northrim Bancorp (NRIM) Stock a Solid Choice Right Now? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Aug 06, 7:46AM CDT
Northrim Bancorp is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.
NRIM: 29.03 (+0.43)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Texas Instruments' $2B Notes Fuel Acquisition Ambitions

Pushing Forward with Big Dollars Texas Instruments is setting the stage with an ambitious move by pricing $2.0 billion in investment-grade notes, preparing to shake things up with an acquisition. It's not every day you see a player like TXN dipping into the bond market with such confidence, yet here we are. Four series of senior unsecured notes are slated for issuance on...

Honeywell Aerospace Faces Lawsuit After Stock Tumbles 23%

Honeywell's Bumpy Ride Rattles Investors Something's brewing over at Honeywell Aerospace, Inc. (NASDAQ:HONA) and it's not your regular cup of joe. Investors, brace yourselves, because a securities fraud class action lawsuit is stacking up against them. With shares plummeting 23.16% in a whirlwind of a market day, it's kind of hard not to get a little riled up, isn't it?...

Flagstar Faces Heat: 9.2% Stock Drop Spurs Probe

Flagstar's Descent: What Led to the Stock Tumble? And here we go again with a big name in finance taking a hit right between the eyes. Flagstar Bank, under ticker NYSE:FLG, saw its shares plummet by over 9.2% on October 23, 2026. This isn't just a blip—it's a spill. The backdrop here is an eye-watering $12.9 billion loan book tied to rent-regulated apartment buildings....

Costa Rican Firms Target Aerospace Supply Chain Gains

Today's spotlight swings on a gutsy move by 10 Costa Rican aerospace companies hustling for a foothold on the global stage. These folks aren't just sitting back; they're throwing their hats in the ring at the NBAA-BACE shindig down in the neon glare of Las Vegas, aiming to muscle into the aerospace supply chain — a cold, hard leap that's a mix of grit and ambition....

San Ysidro Urgent Care Addresses Care Desert in San Diego

A Long Overdue Remedy in San Diego Healthcare access shouldn't be a roll of the dice based on where you live, but for too many folks in Southeastern San Diego, that’s been the sad reality. Today, though, there's a new twist in the tale. Blue Shield of California Promise Health Plan just dropped a hefty $1 million into an urgent care facility that’s more than bricks...

Ericsson Executes Bold Share Buyback Plan in Oct.

Ericsson Kicks Off October with Major Share Repurchases Ericsson's taking bold steps in consolidating shareholder value, and folks, this ain't your run-of-the-mill stock-in-the-drawer move. Between October 19 and 23, 2026, Ericsson picked up 500,000 of its own Class B shares. Yep, you heard right—half a million shares just like that, with a neat price tag rounding out...

Artprice Champions Creative Freedom with AI in 2026

AI and the Creative Reawakening As the autumn of 2026 rolls in, publishing circles are buzzing over artificial intelligence's role in artistry. Weekly updates hailing rejection, tolerance, or adaptation of AI in writing stir the pot. Yet, Artprice by Artmarket stands out by anchoring creative freedom and responsibility in the spotlight. Grounded on an initiative launched...

Ouma Connect Streamlines Surrogacy Medical Clearance

A Game Changer for Surrogacy Agencies When we talk about innovation, we often focus on the flashiest tech in finance or the buzz of a scorching hot stock. But here's Ouma Health, shifting gears in a sector many traders don't blink at—surrogacy. They're unveiling Ouma Connect, a portal pulling back the curtain on medical clearances for gestational-carrier candidates....

Netcapital's 28.62% Plunge: A Fraudulent Drama Unfolds

Netcapital: The Plunge Heard 'Round the Market There it is, clear as day—Netcapital’s (NASDAQ: NCPL) stock plummeting 28.62% like a lead balloon. Shareholders had to watch in horror as pieces of their investments seemed to evaporate, all thanks to a swirl of alleged fraud. You can't just shrug off accusations that a company you've betted on has been cooking its books,...

WuXi AppTec Boosts Guidance Amid Strong CRDMO Growth

Unpacking WuXi AppTec's Latest Performance Boost WuXi AppTec, the pharmaceutical giant, isn't just coasting on its past successes. The way they're riding the contract research, development, and manufacturing (CRDMO) train straight through Q1 to Q3 of 2026 shows they're not just here for show. They've hiked up the stakes with strong metrics across the board, warranting a...